GlassScriptPhysician profile
Jane M Wilson
NPI 1174686646
$2,624.41
in general payments reported to CMS, 2019-2025
13 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $537 · 2022: $1,034 · 2023: $627 · 2024: $115 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $481.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $435.53 | 2021-2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $290.18 | 2021-2022 | |
| Fresenius USA Marketing, INC. | $281.06 | 2022-2025 | Velphoro, Velphoro |
| Genzyme Corporation | $250.00 | 2023-2025 | |
| Amgen INC. | $242.05 | 2021-2023 | Parsabiv |
| Sanofi-Aventis U.S. LLC | $121.53 | 2023 | |
| Ardelyx, INC. | $115.28 | 2024 | Xphozah 30 Mg |
| Opko Pharmaceuticals, LLC | $97.84 | 2023 | Rayaldee |
| Cormedix INC. | $92.88 | 2025 | Defencath |
| Bayer Healthcare Pharmaceuticals INC. | $83.11 | 2021 | |
| Glaxosmithkline, LLC. | $67.24 | 2022 | |
| Inari Medical, INC. | $65.84 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.